Baylosis, Annaly F.

HRN: 27-04-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/09/2025
07/16/2025
IV
500mg
Q8
Cholecystolithiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: